Daniel P. Larson

1.0k total citations
23 papers, 525 citations indexed

About

Daniel P. Larson is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Daniel P. Larson has authored 23 papers receiving a total of 525 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Immunology and 5 papers in Oncology. Recurrent topics in Daniel P. Larson's work include Hepatitis C virus research (5 papers), HIV/AIDS drug development and treatment (4 papers) and Lymphoma Diagnosis and Treatment (4 papers). Daniel P. Larson is often cited by papers focused on Hepatitis C virus research (5 papers), HIV/AIDS drug development and treatment (4 papers) and Lymphoma Diagnosis and Treatment (4 papers). Daniel P. Larson collaborates with scholars based in United States, United Kingdom and China. Daniel P. Larson's co-authors include Clayton H. Heathcock, Rafaël Fonseca, Robert A. Kyle, Vikas Gupta, Rhett P. Ketterling, S. Vincent Rajkumar, Shaji Kumar, John A. Lust, Wilson I. Gonsalves and Angela Dispenzieri and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Clinical Microbiology and Journal of Medicinal Chemistry.

In The Last Decade

Daniel P. Larson

21 papers receiving 500 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Daniel P. Larson United States	10	222	154	147	141	106	23	525
Zilun Hu United States	11	175 0.8×	62 0.4×	41 0.3×	132 0.9×	29 0.3×	23	460
Leanne Cartee United States	14	357 1.6×	32 0.2×	51 0.3×	82 0.6×	59 0.6×	27	646
Chang-Rung Chen United States	7	666 3.0×	161 1.0×	30 0.2×	51 0.4×	49 0.5×	17	922
Chad D. Walls United States	14	316 1.4×	36 0.2×	78 0.5×	30 0.2×	57 0.5×	24	705
Birgit Zech Germany	6	273 1.2×	57 0.4×	55 0.4×	94 0.7×	38 0.4×	7	427
Young‐Choon Moon United States	10	451 2.0×	31 0.2×	29 0.2×	84 0.6×	28 0.3×	23	661
Paul Guéguen France	14	167 0.8×	62 0.4×	192 1.3×	10 0.1×	136 1.3×	48	669
Jingjin Gao United States	8	123 0.6×	160 1.0×	35 0.2×	12 0.1×	92 0.9×	11	337
P Steinmetzer Germany	12	148 0.7×	64 0.4×	37 0.3×	51 0.4×	27 0.3×	19	356
Christina Rau Germany	9	283 1.3×	32 0.2×	74 0.5×	27 0.2×	33 0.3×	10	350

Countries citing papers authored by Daniel P. Larson

Since Specialization

Citations

This map shows the geographic impact of Daniel P. Larson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel P. Larson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel P. Larson more than expected).

Fields of papers citing papers by Daniel P. Larson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel P. Larson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel P. Larson. The network helps show where Daniel P. Larson may publish in the future.

Co-authorship network of co-authors of Daniel P. Larson

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel P. Larson. A scholar is included among the top collaborators of Daniel P. Larson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel P. Larson. Daniel P. Larson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Dasari, Surendra, Jason D. Theis, Matthew T. Howard, et al.. (2025). Dual amyloidosis: A clinicopathologic and proteomic analysis of 111 patients. Human Pathology. 166. 105954–105954.

Chiu, April, Surendra Dasari, Samih H. Nasr, et al.. (2024). Salivary gland amyloidosis: Proteomic identification and clinicopathologic characterization of 57 cases. Human Pathology. 151. 105628–105628. 1 indexed citations

Nathoo, Nabeela, Daniel P. Larson, Yong Guo, et al.. (2024). Central nervous system crystal‐storing histiocytosis: A case report and literature review. European Journal of Neurology. 32(1). e16528–e16528. 1 indexed citations

Rehder, Catherine, Brynn Levy, Gopalrao V.N. Velagaleti, et al.. (2024). Conventional Cytogenetic Analysis of Constitutional Abnormalities: A 20-Year Review of Proficiency Test Results From the College of American Pathologists/American College of Medical Genetics and Genomics Cytogenetics Committee. Archives of Pathology & Laboratory Medicine. 149(3). 211–216. 2 indexed citations

Anagnostou, Theodora, Zhi-Zhang Yang, Shahrzad Jalali, et al.. (2023). Characterization of immune exhaustion and suppression in the tumor microenvironment of splenic marginal zone lymphoma. Leukemia. 37(7). 1485–1498. 7 indexed citations

Larson, Daniel P., et al.. (2023). Richter Transformation of Chronic Lymphocytic Leukemia—Are We Making Progress?. Current Hematologic Malignancy Reports. 18(5). 144–157. 3 indexed citations

Yang, Zhi-Zhang, Hyo Jin Kim, Hongyan Wu, et al.. (2023). T-cell phenotype including CD57+ T follicular helper cells in the tumor microenvironment correlate with a poor outcome in follicular lymphoma. Blood Cancer Journal. 13(1). 124–124. 11 indexed citations

Roden, Anja C., Christopher Hartley, Jess F. Peterson, et al.. (2023). Dedifferentiation of B-lymphoblastic leukemia/lymphoma with t(9;22) BCR::ABL1 to an undifferentiated neoplasm with strong keratin expression in a patient receiving blinatumomab. SHILAP Revista de lepidopterología. 31. 300688–300688.

Larson, Daniel P., Yassmine Akkari, Daniel L. Van Dyke, et al.. (2020). Conventional Cytogenetic Analysis of Hematologic Neoplasms: A 20-Year Review of Proficiency Test Results From the College of American Pathologists/American College of Medical Genetics and Genomics Cytogenetics Committee. Archives of Pathology & Laboratory Medicine. 145(2). 176–190. 3 indexed citations

10.

Kronzer, Vanessa L., Daniel P. Larson, Cynthia S. Crowson, et al.. (2019). Occurrence and aetiology of gastrointestinal perforation in patients with vasculitis.. PubMed. 37 Suppl 117(2). 32–39. 4 indexed citations

11.

Rajkumar, S. Vincent, Vikas Gupta, Rafaël Fonseca, et al.. (2013). Impact of primary molecular cytogenetic abnormalities and risk of progression in smoldering multiple myeloma. Leukemia. 27(8). 1738–1744. 145 indexed citations

12.

Hutchinson, Douglas K., Larry L. Klein, Daniel P. Larson, et al.. (2008). Hepatitis C NS5B polymerase inhibitors: 4,4-Dialkyl-1-hydroxy-3-oxo-3,4-dihydronaphthalene-3-yl benzothiadiazine derivatives. Bioorganic & Medicinal Chemistry Letters. 18(14). 3887–3890. 13 indexed citations

13.

Holubar, Stefan D., et al.. (2008). Minimally invasive total Proctocolectomy with Brooke Ileostomy for Ulcerative Colitis. Inflammatory Bowel Diseases. 14. S23–S23. 3 indexed citations

14.

Larson, Daniel P., Rolf Wagner, Todd W. Rockway, et al.. (2007). Synthesis and SAR of novel 1,1-dialkyl-2(1H)-naphthalenones as potent HCV polymerase inhibitors. Bioorganic & Medicinal Chemistry Letters. 18(2). 568–570. 16 indexed citations

15.

Lu, Liangjun, Sherie Masse, Ron Pithawalla, et al.. (2007). Identification and characterization of mutations conferring resistance to an HCV RNA-dependent RNA polymerase inhibitor in vitro. Antiviral Research. 76(1). 93–97. 29 indexed citations

16.

Chen, Chih‐Ming, Yupeng He, Liangjun Lu, et al.. (2007). Activity of a Potent Hepatitis C Virus Polymerase Inhibitor in the Chimpanzee Model. Antimicrobial Agents and Chemotherapy. 51(12). 4290–4296. 39 indexed citations

17.

Kym, Philip R., Michael E. Kort, Michael J. Coghlan, et al.. (2003). Nonsteroidal Selective Glucocorticoid Modulators: The Effect of C-10 Substitution on Receptor Selectivity and Functional Potency of 5-Allyl-2,5-dihydro-2,2,4-trimethyl-1H-[1]benzopyrano[3,4-f]quinolines. Journal of Medicinal Chemistry. 46(6). 1016–1030. 86 indexed citations

18.

Larson, Daniel P. & Clayton H. Heathcock. (1997). Total Synthesis of Tricolorin A. The Journal of Organic Chemistry. 62(24). 8406–8418. 59 indexed citations

19.

Lyssikatos, Joe, J. P. Clancy, John P. Dirlam, et al.. (1997). Cyclic homopentapeptides 2. Synthetic modifications of viomycin. Bioorganic & Medicinal Chemistry Letters. 7(9). 1145–1148. 9 indexed citations

20.

Dixit, Vivek, S. Quan, Paul Martin, et al.. (1995). Evaluation of a novel serotyping system for hepatitis C virus: strong correlation with standard genotyping methodologies. Journal of Clinical Microbiology. 33(11). 2978–2983. 69 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact